The Newest Weapon to Fight Myopia

✅ What is the recently FDA-approved Stellest™ Lens?

The Stellest™ lens is an innovative myopia control lens developed by EssilorLuxottica. It is specifically designed to slow down the progression of myopia in children using advanced optical technology.

It combines:

• Single-vision lens correction (for clear central vision), and
• A constellation of aspherical lenslets spread across the lens in a patented “H.A.L.T.”* technology zone (*Highly Aspherical Lenslet Target), which creates a myopic defocus signal to help slow eye elongation – the primary cause of myopia progression.

📅 When was the Stellest™ Lens invented?

• The Stellest™ lens was officially launched in 2020, following several years of research and clinical trials.
• A 2-year clinical study conducted in China (with Wenzhou Medical University) showed that Stellest lenses slowed myopia progression by 67% on average compared to single-vision lenses, when worn 12+ hours a day.

🔍 Key Features:

• Myopia control: Slows progression of myopia in children (less effective age 12, 13, 14)
• Clear central vision: Like regular prescription lenses.
• Lenslet technology: H.A.L.T. technology with over 1,000 invisible lenslets arranged in concentric rings.
• Looks like a normal lens: Nearly invisible design.
• Good adjunct to use with Atropine and MiSight contact lenses